Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07047469
Recruiting Not applicable

Ultrasound-assisted Spinal Anesthesia in Midline Versus Paramedian Approach in Adult Orthopedic Surgery

NCT07047469 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sohag University
Phase
Not applicable
Started
2025-06-13
Last updated
2025-07-02

Condition(s) studied

Anesthesia; Functional

Investigational drug(s) / intervention(s)

Group (1): spinal anesthesia with median approachGroup (2): spinal anesthesia with paramedian approach

Group (1): spinal anesthesia with median approach: patients undergoing orthopedic surgery will receive spinal anesthesia with median approach under ultrasound guided techniques

Group (2): spinal anesthesia with paramedian approach: patients undergoing orthopedic surgery will receive spinal anesthesia with paramedian approach under ultrasound guided techniques

Study summary

This study aims to compare between the two methods (midline and paramedian approach of spinal anesthesia guided by ultrasound) by the number of needle passes required to successful dural puncture.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Patients will perform orthopedic surgery * Physical state I or II according to ASA classification * Age between (18 - 50 ) * Body mass index less than 30 Exclusion Criteria: * Patient refusal . * Local infection at the puncture site . * Allergy to any of the drugs to be administrated . * Old age patients * Obese patients * Previous spinal surgery . * Spinal stenosis . * Multiple sclerosis . * Coagulopathy. * Hypovolemia . * Systemic infection . * Aortic stenosis . * Spina bifida and back deformity .

Primary outcome measure(s)

  • The severity of back pain in patients that will receive spinal anesthesia by median versus paramedian approach — 24 hours, 72 hours, and 1 week after spinal anesthesia.
    pain measurement by numerical rating scale (NRS)

Trial sites (1)

FacilityCityRegionStatus
Sohag University Hospital Sohag Egypt Recruiting

More Sohag University trials in Egypt

Colitis Patterns in Patients With Lower GI Symptoms Starting soon
Zadek Osteotomy for Treatment of Haglund's Syndrome Recruiting
Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patient. Active, not recruiting
Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders Starting soon
Accuracy of Transabdominal Ultrasound in Predicting Intraperitoneal Adhesions Prior to Laparoscopy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07047469 on ClinicalTrials.gov ↗ ← All trials in Egypt